The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells

被引:14
|
作者
Chen, Lei [1 ]
Lagunoff, Michael [1 ]
机构
[1] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
KSHV; interleukin; 6; IL-6; vIL-6; Kaposi's sarcoma;
D O I
10.1016/j.virol.2006.09.044
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's Sarcoma-associated herpesvirus encodes a homolog of the human cellular interleukin-6 that may play a formative role in many KSHV-related diseases. While the viral IL-6 can signal similarly to its human counterpart little is known about the role of vIL-6 during KSHV infection. Using homologous recombination and selection in eukaryotic cells, a KSHV isolate was purified that does not express vIL-6 as was a control recombinant that left vIL-6 intact. The two viruses establish and maintain latency to similar levels in BJAB B-cells, reactivate to similar levels in B-cells and Monkey kidney cells and have very similar KSHV gene expression patterns. BJAB cells expressing KSHV survive better than the parental BJAB cells in low serum and the vIL-6 deletion does not abrogate this growth advantage. Thus vIL-6 is not essential for establishment, maintenance, or reactivation from latency in cell culture and is not involved in the survival of infected BJAB B-cells in low serum. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:425 / 435
页数:11
相关论文
共 50 条
  • [41] Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations
    Polizzotto, Mark N.
    Uldrick, Thomas S.
    Wang, Victoria
    Aleman, Karen
    Wyvill, Kathleen M.
    Marshall, Vickie
    Pittaluga, Stefania
    O'Mahony, Deirdre
    Whitby, Denise
    Tosato, Giovanna
    Steinberg, Seth M.
    Little, Richard F.
    Yarchoan, Robert
    BLOOD, 2011, 118 (21) : 683 - 684
  • [42] NEDDylation Is Essential for Kaposi's Sarcoma- Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target
    Hughes, David J.
    Wood, Jennifer J.
    Jackson, Brian R.
    Baquero-Perez, Belinda
    Whitehouse, Adrian
    PLOS PATHOGENS, 2015, 11 (03)
  • [43] Dysregulation of the miR-30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication
    Harper, Katherine L.
    Mottram, Timothy J.
    Anene, Chinedu A.
    Foster, Becky
    Patterson, Molly R.
    McDonnell, Euan
    Macdonald, Andrew
    Westhead, David
    Whitehouse, Adrian
    EMBO REPORTS, 2022, 23 (05)
  • [44] Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor
    Adam, Nina
    Rabe, Bjoern
    Suthaus, Jan
    Groetzinger, Joachim
    Rose-John, Stefan
    Scheller, Juergen
    JOURNAL OF VIROLOGY, 2009, 83 (10) : 5117 - 5126
  • [45] DERIVATION OF GERMLINE COMPETENT EMBRYONIC STEM-CELLS WITH A COMBINATION OF INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR
    NICHOLS, J
    CHAMBERS, I
    SMITH, A
    EXPERIMENTAL CELL RESEARCH, 1994, 215 (01) : 237 - 239
  • [46] Human myeloma cells promote the recruitment of osteoblast precursors: Mediation by interleukin-6 and soluble interleukin-6 receptor
    Karadag, A
    Scutt, AM
    Croucher, PI
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (10) : 1935 - 1943
  • [47] Effects of interleukin-6 (IL-6) on cytotrophoblastic cells
    Meisser, A
    Cameo, P
    Islami, D
    Campana, A
    Bischof, P
    MOLECULAR HUMAN REPRODUCTION, 1999, 5 (11) : 1055 - 1058
  • [48] Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation
    Gabaev, Ildar
    Williamson, James C.
    Crozier, Thomas W. M.
    Schulz, Thomas F.
    Lehner, Paul J.
    CELL REPORTS, 2020, 33 (02):
  • [49] Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines
    Wu, Yiquan
    Wang, Victoria
    Yarchoan, Robert
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [50] Sphingosine Kinase-2 Maintains Viral Latency and Survival for KSHV-Infected Endothelial Cells
    Dai, Lu
    Plaisance-Bonstaff, Karlie
    Voelkel-Johnson, Christina
    Smith, Charles D.
    Ogretmen, Besim
    Qin, Zhiqiang
    Parsons, Chris
    PLOS ONE, 2014, 9 (07):